These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 11366890)
21. IL-2 for HIV: the long march toward FDA approval. Food and Drug Administration. Sterritt C GMHC Treat Issues; 1997 Sep; 11(9):1-3. PubMed ID: 11364749 [TBL] [Abstract][Full Text] [Related]
22. FDA notifications. Tenofovir in India receives tentative approval. AIDS Alert; 2009 Jun; 24(6):70-1. PubMed ID: 19544609 [No Abstract] [Full Text] [Related]
23. FDA approves Viread for HIV-1 infection. FDA Consum; 2002; 36(1):5. PubMed ID: 11881601 [No Abstract] [Full Text] [Related]
25. More trouble for adefovir. Gilden D GMHC Treat Issues; 1999 Apr; 13(4):3. PubMed ID: 11366975 [TBL] [Abstract][Full Text] [Related]
26. Tenofovir for the treatment of hepatitis B virus. Jenh AM; Thio CL; Pham PA Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994 [TBL] [Abstract][Full Text] [Related]
27. Tenofovir: FDA hearing October 3, public comment deadlines September 26. James JS AIDS Treat News; 2001 Aug; (370):3-4. PubMed ID: 11570163 [No Abstract] [Full Text] [Related]
28. Tenofovir DF expanded access. Criteria for U.S. program. AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565 [TBL] [Abstract][Full Text] [Related]
29. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]